Bard Updates First Quarter Guidance.Business Editors MURRAY HILL, N.J.--(BUSINESS WIRE)--March 9, 2004 C. R. Bard C. R. Bard, Inc. (NYSE: BCR) is one of the large S&P 500 companies of the United States, a surgical specialties and hospital medical device manufacturer in Murray Hill, New Jersey. It is named after its founder, who sold the company within only a few years of its founding. , Inc. (NYSE-BCR) today announced that it expects first quarter 2004 results to exceed prior guidance. The company now expects earnings per share between $1.02 and $1.04 on a net sales Net Sales The amount a seller receives from the buyer after costs associated with the sale are deducted. Notes: This amount is calculated by subtracting the following items from gross sales: merchandise returned for credit, allowances for damaged or missing goods, freight increase in the range between 8 and 11 percent in constant currency. In its fourth quarter 2003 earnings call, the company had indicated that it expected to earn between $1.00 and $1.01 per share on a net sales increase of 8 percent in constant currency. Chairman and Chief Executive Officer, Timothy M. Ring, commented, "We have entered into 2004 with some nice momentum and are pleased to be experiencing a strong first quarter. Currently, our full-year guidance remains unchanged." C. R. Bard, Inc., (www.crbard.com) headquartered in Murray Hill, N.J., is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of vascular, urology urology Medical specialty dealing with the urinary system and male reproductive organs. It traces its origin to medieval lithologists, itinerant healers who specialized in surgical removal of bladder stones. , oncology, and surgical specialty surgical specialty A specialty of health care in which interventions constitute a significant component of Pt management Examples OB/GYN, ophthalmology, ENT, surgery–cardiothoracic, colorectal, general, neurologic, orthopedic, plastic, urology. products. This press release contains forward-looking statements, the accuracy of which is necessarily subject to risks and uncertainties. Please refer to our September 30, 2003 Form 10-Q Form 10-Q See 10-Q. for a statement with regard to forward-looking statements, including disclosure of the factors that could cause actual results to differ materially from those expressed or implied. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion